RAAS activation loads the failing ventricle from two directions at once. Aldosterone-driven sodium and water retention expands plasma volume, which increases venous return and raises ventricular filling pressure — that is, it raises preload. Angiotensin II-mediated arteriolar constriction raises systemic vascular resistance, which increases the pressure the ventricle must generate to eject blood — that is, it raises afterload. The failing ventricle therefore receives a larger volume and must push it against a higher resistance.
The two effects interact. Higher preload stretches the myocytes and, through the Frank-Starling relationship, can transiently support stroke volume, but the failing ventricle sits near the plateau of its depressed curve, so the extra volume mostly raises filling pressures rather than output. Those elevated filling pressures are transmitted backward into the pulmonary and systemic venous beds, producing congestion. Meanwhile, the raised afterload directly reduces stroke volume, since a weakened ventricle is more sensitive to outflow resistance. The net effect is that RAAS defends blood pressure at the cost of increased congestion and increased myocardial workload, and the sustained vasoconstriction and volume expansion contribute to the structural remodeling that will be examined in the next chapter.